Precigen (PGEN) Invested Capital (2012 - 2023)

Precigen (PGEN) has 12 years of Invested Capital data on file, last reported at $13.8 million in Q1 2023.

• On a quarterly basis, Invested Capital rose 8326.22% year-over-year to $13.8 million in Q1 2023; TTM through Dec 2023 was $13.8 million, a 89.01% decrease from a year earlier, with the FY2022 full-year figure at $43.2 million, up 58304.05% from the prior year.
• Invested Capital for Q1 2023 stood at $13.8 million, down from $43.2 million in the prior quarter.
• Over the last five years, Invested Capital for PGEN reached as high as $82.1 million in Q3 2022 and fell as low as $19000.0 in Q4 2020.
• Historically, Invested Capital has averaged $8.9 million across 5 years, with a median of $169500.0 in 2020.
• Across the five-year window, Invested Capital slumped 93.31% in 2020 and soared 58304.05% in 2022, its largest moves.
• Year by year, Invested Capital stood at $51000.0 in 2019, then tumbled by 62.75% to $19000.0 in 2020, then soared by 289.47% to $74000.0 in 2021, then surged by 58304.05% to $43.2 million in 2022, then tumbled by 68.03% to $13.8 million in 2023.
• Per Business Quant data, the three most recent Invested Capital figures were $13.8 million in Q1 2023, $43.2 million in Q4 2022, and $82.1 million in Q3 2022.